Comparison of the Western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to Verocytotoxin 1

Journal of Clinical Microbiology

Volumn 35, Issue 3, 1997, Pages 609-613

  Reymond, D ^a,b   Karmali, M A ^a,b   Clarke, I ^b   Winkler, M ^b   Petric, M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; TOXIN ANTIBODY; VEROTOXIN;

ANIMAL MODEL; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ESCHERICHIA COLI; NEGIBACTERIA; ORYCTOLAGUS CUNICULUS;

EID: 0031044875     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.3.609-613.1997     Document Type: Article

References (40)

1. Barrett, T. J., J. H. Green, P. M. Griffin, A. T. Pavia, S. M. Ostroff, and I. K. Wachsmuth. 1991. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr. Microbiol. 23:189-195.
2. Bielasczewska, M., M. A. Karmali, and M. Petric. 1994. Localization of verocytotoxin (VT) 2 and antigenic cross-reactivity of VT1 and VT2 in the rabbit model. In M. Karmali and A. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infection. Elsevier Sciences, Amsterdam, The Netherlands.
3. Bitzan, M., K. Ludwig, M. Klemt, H. König, J. Büren, and D. E. Müller-Wiefel. 1993. The role of Escherichia coli infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol. Infect. 110:183-196.
4. Bridgwater, F. A. J., R. S. Morgan, K. E. K. Rowson, and G. P. Wright. 1955. The neurotoxin of Shigella shigae. Morphological and functional lesions produced in the central nervous system of rabbits. Br. J. Exp. Pathol. 36: 447-453.
5. Brown, J. E., M. A. Ussery, S. H. Leppla, and S. W. Rothman. 1980. Inhibition of protein synthesis by Shiga toxin. Activation of the toxin and inhibition of peptide elongation. FEBS Lett. 117:84-88.
6. Caprioli, A., I. Luzzi, F. Rosmini, P. Pasquini, R. Cirrincione, A. Gianviti, M. Matteucci, and G. Rizzoni. 1992. Hemolytic-uremic syndrome and vero cytotoxin-producine Escherichia coli infection in Italy. J. Infect. Dis. 166:154-158.
7. Caprioli, A., I. Luzzi, L. Seganti, M. Marchetti, M. Karmali, I. Clarke, and B. Boyd. 1994. Frequency and nature of verocytotoxin 2 (VT2) neutralizing activity in human and animal sera, p. 353-356. In M. Karmali and A. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infection. Elsevier Sciences, Amsterdam, The Netherlands.
8. Chart, H., D. Law, B. Rowe, and D. W. K. Acheson. 1993. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin. J. Clin. Pathol. 46:1053-1054.
9. Cohen, A., V. Madrid-Marina, Z. Estrov, M. Freedman, C. A. Lingwood, and H. Dosch. 1990. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2:1-8.
10. Greatorex, J. S., and G. M. Thorne. 1994. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J. Clin. Microbiol. 32:1172-1178.
11. Griffin, P. M. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, Ltd., New York, N.Y.
12. Harari, I., A. Donohue-Rolfe, G. T. Keusch, and R. Arnon. 1988. Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity. Infect. Immun. 56:1618-1624.
13. Head, S. C., M. A. Karmali, and C. A. Lingwood. 1991. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. J. Biol. Chem. 266:3617-3621.
14. Karmali, M. A. 1989. Infection by Verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
15. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
16. Karmali, M. A., M. Petric, M. Winkler, M. Bielasczewska, J. Brunton, N. van de Kar, T. Morooka, G. B. Nair, S. E. Richardson, and G. S. Arbus. 1994. Enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies to Escherichia coli Verocytotoxin 1. J. Clin. Microbiol. 32:1457-1463.
17. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet i:619-620.
18. Konowalchuk, J., N. Dickie, S. Stavric, and J. I. Speirs. 1978. Properties of an Escherichia coli cytotoxin. Infect. Immun. 20:575-577.
19. Knonwalchuk, J., J. I. Speirs, and S. Stavric. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-779.
20. Levine, M. M., J. McEwen, G. Losonsky, M. Reymann, I. Harari, J. E. Brown, D. N. Taylor, A. Donohue-Rolfe, D. Cohen, M. Bennish, Y. L. Lim, and R. Arnon. 1992. Antibodies to Shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J. Clin. Microbiol. 30:1636-1641.
21. Lindberg, A. A., J. E. Brown, N. Strömberg, M. Westling-Ryd, J. E. Schultz, and K.-A. Karlsson. 1987. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262: 1779-1785.
22. Lingwood, C. A., H. Law, S. E. Richardson, M. Petric, J. L. Brunton, S. de Grandis, and M. Karmali. 1987. Glycolipid binding of natural and recombinant Escherichia coli produced Verotoxin in-vitro. J. Biol. Chem. 262: 8834-8839.
23. O'Brien, A. D., M. A. Karmali, and S. M. Scotland. 1994. A proposal for rationalizing the nomenclature of the Escherichia coli cytotoxins, p. 147-150. In M. A. Karmali and A. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam, The Netherlands.
24. O'Brien, A. D., G. D. LaVeck, M. R. Thompson, and S. B. Formal. 1982. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J. Infect. Dis. 146:763-769.
25. O'Brien, A. D., V. L. Tesh, A. Donohue-Rolfe, M. P. Jackson, S. Olsnes, K. Sandvig, A. A. Lindberg, and G. T. Keusch. 1992. Shiga toxin: biochemistry, genetics, mode of action and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180:65-94.
26. Obrig, T. G., P. J. D. Vecchio, J. E. Brown, T. P. Moran, B. M. Rowland, T. K. Judge, and S. W. Rothman. 1988. Direct cytotoxic action of shiga toxin on human vascular endothelial cells. Infect. Immun. 56:2373-2378.
27. Petric, M., M. A. Karmali, S. Richardson, and R. Cheung. 1987. Purification and biological properties of Escherichia coli verocytotoxin. FEMS Microbiol. Lett. 41:63-68.
28. Reymond, D., R. P. Johnson, M. A. Karmali, M. Petric, M. Winkler, S. Johnson, K. Rahn, S. Renwick, J. Wilson, R. C. Clarke, and J. Spika. 1996. Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J. Clin. Microbiol. 34:2053-2057.
29. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R. Smith. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producins Escherichia coli infectiuns. Hum. Pathol. 19:1102-1108.
30. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric, N. F. Olivieri, and M. A. Karmali. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
31. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
32. Robson, W. L. M., A. K. Leung, and D. J. Miller-Hughes. 1993. Recurrent hemorrhagic colitis caused by Escherichia coli O157:H7. Pediatr. Infect. Dis. J. 12:699-701.
33. Rowe, P. C., E. Orrbine, G. A. Wells, and P. N. McLaine. 1991. Epidemiology of hemolytic uremic syndrome in Canadian children from 1986 to 1988. J. Pediatr. 119:218-224.
34. Sandvig, K., S. Olsnes, J. E. Brown, O. W. Peterson, and B. van Deurs. 1989. Endocytosis from coated pigs of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108:1331-1343.
35. Seidah, N. G., A. Donohue-Rolfe, C. Lazure, F. Auclair, G. T. Keusch, and M. Chretein. 1986. Complete amino acid sequence of Shigella toxin B-chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. J. Biol. Chem. 261:13928-13931.
36. Siegler, R. L., P. M. Griffin, and T. J. Barrett. 1993. Recurrent hemolvtic uremic syndrome secondary to Escherichia coli O157:H7 infection. Pediatrics 91:666-668.
37. Smith, J. W. G., and J. G. Collee. 1993. Tetanus, p. 331-351. In G. R. Smith and C. S. F. Easmon (ed.), Topley and Wilson's principles of bacteriology, virology, and immunity, 8th ed. vol. 3. Bacterial diseases. Mosby Yearbook, Inc., St. Louis, Mo.
38. Thomas, A., H. R. Smith, and B. Rowe. 1993. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157. J. Clin. Microbiol. 31:1700-1703.
39. Towbin, M., T. Staehlin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
40. Wilson, J. B., R. C. Clarke, S. A. Renwick, K. Rahn, R. P. Johnson, M. A. Karmali, H. Lior, D. Alves, C. L. Gyles, K. S. Sandhu, S. A. McEwen, and J. S. Spika. 1996. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J. Infect. Dis. 174:1021-1027.